Inflammatory processes are involved in the initiation and maintenance of labor, suggesting that toll-like receptor (TLR) activity within gestation-associated tissues, such as the placenta, might contribute to the process of parturition. Expression of transcripts for TLR1-TLR10 was examined in term (.37 wk of gestation) human placentas collected in the absence of labor (elective caesarean sections; ECS; n ¼ 11) and after the completion of labor (normal vaginal delivery; NVD; n ¼ 12). Placental explants were cultured in the presence of agonists for TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, and TLR9, and cytokine production after 24 h was examined. All placentas expressed transcripts for TLR1-TLR10. Reactivity to all agonists except CpG oligonucleotides was observed, indicating that, other than TLR9, all of the receptors studied yielded functional responses. Placental explants prepared from NVD placentas (n ¼ 17) produced significantly more TNFA in response to lipopolysaccharide (TLR4 agonist) and resiquimod (TLR7/8 agonist) than explants from ECS placentas (n ¼ 17). In contrast, gene expression analysis revealed that only transcripts for TLR2 and TLR5 were significantly elevated in association with labor. The human term placenta expresses a variety of functional TLRs, indicating that this family of receptors has an important role in parturition via as yet undetermined cell types and signaling pathways.
INTRODUCTION
Cytokines and chemokines typically involved in inflammatory responses contribute to reproductive processes, including parturition. In particular, gestation-associated tissues such as the placenta can produce TNFA, IL1A, IL6, IL8, and IL10 as well as many other cytokines and chemokines, constitutively and/or in response to lipopolysaccharide (LPS) [1, 2] . As Tolllike receptors (TLRs) link not only microbial agonists but endogenous host-derived agonists to the production of inflammatory mediators, it has been postulated that TLRs could provide a mechanism of cytokine production at the maternal-fetal interface and might have a role in the initiation and/or maintenance of labor [3] . However, there is little published data about TLR expression and/or function at the maternal-fetal interface.
The placenta is a pregnancy-specific component of the innate immune system constituting a physical and immunological barrier against invading infectious agents. TLR activity within cells of the placenta would support such a role. Transcripts for TLRs 1-10 have been demonstrated in the term human placenta as well as in the trophoblastic choriocarcinoma cell lines JAR and BeWo [4] [5] [6] . Various cell types in the preterm and term placenta, including Hofbauer cells and villous, extravillous, and intermediate trophoblasts, express TLR2 and/or TLR4 protein [7] [8] [9] [10] with preferential expression of TLR4 on the trophoblast plasma membrane facing the maternal blood in the intervillous spaces reported [9] . Similarly, choriocarcinoma cell lines express cell surface TLR2 and TLR4 and intracellular TLR9 [6] . Functional activity of TLR2-TLR4 have been reported for first and third trimester trophoblast/placenta [3, 7, 10, 11] , and choriocarcinoma cell lines are responsive to TLR2-TLR4 and TLR9 agonists [6] .
The functionality of TLRs other than TLR2 and TRL4 within the term human placenta and/or primary trophoblast remains unknown. Therefore, we undertook an investigation of the expression and activity of TLRs 1-10 in the term human placenta in the absence of labor and following completion of spontaneous onset labor at term (.37 wk of gestation) to explore whether TLRs expressed in the term human placenta are functional and whether changes in the expression and/or activity of these receptors are associated with spontaneous term labor.
MATERIALS AND METHODS

Samples
Placentae were collected after delivery from otherwise healthy pregnant women with a singleton fetus (gestational age .37 wk) to provide two groups (n ¼ 17/group): 1) term nonlabored group that consisted of women who had for elective caesarean section (ECS) due to varied obstetric reasons, including cephalopelvic disproportion, breech presentation, and/or previous caesarean section, and 2) term labored group that consisted of women with a normal vaginal delivery (NVD) following spontaneous onset of labor. Women with autoimmune or other immunological disorders (including infectious diseases such as HIV) were excluded from the study. All women gave informed written consent, and the study was approved by the South West Wales Local Research Ethics Committee. Gestational age was calculated by ultrasound or by the first day of the last menstrual period. The necessary demographic and the obstetric details were obtained from the hospital notes of both the mothers and babies and are summarized in Table 1 .
Placental Explant Culture
Explant cultures were prepared as described [12] . Briefly, the overlaying decidua basalis on the maternal side of the placenta was removed and 1-mm 3 pieces of placental tissue were taken from different sites across the placenta and placed into sterile calcium/magnesium-free PBS (Invitrogen, UK). Care was taken to avoid contamination with chorioamnion. Tissue was washed repeatedly with PBS to remove contaminating blood and was then minced into smaller pieces (approximately 1-2 mm 3 ). Pieces of placental tissue (0.5g in total) were transferred into each well of a 6-well tissue culture plate (Greiner Bio-one, Germany) containing 2.5mls of Ultraculture medium (Cambrex, Belgium) supplemented with 2 mM Glutamax (Invitrogen) and 100 U/ml Penicillin G, 100 lg/ml streptomycin sulphate, and 0.25 lg/ml amphotericin B (Invitrogen). Care was taken to avoid any blood clots or fibrous tissue.
Optimal levels of all agonists were determined by dose course analysis on placental explants and/or peripheral blood mononuclear cells (e.g., CpG oligonucleotides), and the following final concentrations were used: peptidoglycan (PGN; TLR2, 3lg/ml); poly I:C (TLR3, 25lg/ml); ultrapure LPS (TLR4, 100ng/ml); flagellin (TLR5, 100ng/ml); resiquimod (R848; TLR7/8, 100ng/ml); loxoribine (TLR7/8, 100 lM); single-stranded polyU/LyoVEC complexes (ss Poly, TLR7/8, 1lg/ml); ODN2216 CpG (TLR9, 1lM), and control oligodeoxynucleotide (ODN; 1 lM) (all from Invivogen, UK, or Autogen Bioclear, UK). An unstimulated control was always included. Plates were incubated at 378C in 5% CO 2 for 24 h. Cell/tissue-free culture supernatants were collected by centrifugation and stored at À208C until assayed.
Extreme care was taken to limit LPS/endotoxin contamination during explant preparation. These precautions included the use of disposable plasticware and other consumables (e.g., scissors) whenever possible. All media/reagents were tested by the manufacturers and found to be endotoxin free.
Real-Time Quantitative PCR
Placental tissue biopsies were preserved in RNAlater (Sigma, UK) at À808C. DNA-free RNA was prepared from homogenized tissue using FastPrep FP120A and Bio101 Savant, (Qbiogene, The Netherlands), MiniKit (Qiagen, UK), and DNA-free DNase Kit (Ambion, UK) according to the manufacturers' instructions. Total RNA was quantified, and OD 260 nm /OD 280 nm was determined with ND-3300 Fluorospectrometer (NanoDrop Technologies, UT), while RNA quality was determined using a RNA 6000 Nano LabChip on the Agilent 2100 Bioanalyzer (Agilent Technologies UK Limited, UK). Reverse transcription was performed by incubating 1 lg RNA with murine leukaemia virus reverse transcriptase and random decamers from the RETROscript Kit (Ambion) following the manufacturer's instructions. Confirmation of genomic DNA-free status and successful reverse transcription was obtained by PCR amplification of the S15 ribosomal protein gene.
Real-time PCR for all genes of interest (TLR1-TLR10) and three housekeeping genes was carried out using the iCycler IQ version 3.1 (BioRad, UK). The housekeeping genes, succinate dehydrogenase complex subunit A (SDHA), TATA box binding protein (TBP), and tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ) were selected as they had been shown to be the most stably expressed in the human placenta [13] . All primers were synthesized by MWG-Biotech AG, Germany, using sequences that have been published previously [4, 14] ; the sequence for the primer ID2629, TATA box binding protein (TBP), was obtained using http://medgen.ugent.be/rtprimerdb. These sequences and specific conditions particular to each PCR are listed in Table 2 . All primers were used at 5 lM with the exception of the reverse primer for TLR7, which was used at 15 lM; the magnesium concentration for all reactions was 3 mM with the exception of TLR9, which was 3.5 mM. Broadly, for each real-time quantitative PCR (qPCR), 1 ll cDNA was added to a 20 ll mix containing primers, IQ SYBR-green supermix (Bio-Rad) and nuclease-free water. PCR conditions were 210 s at 958C, 40 cycles of 30 s at 958C, 30 s at the appropriate annealing temperature (Table 2) , 30 s at 728C, and 60 s at 558C. Subsequent melt curve analysis commenced at 558C for 10 s and increased by 0.58C every 10 s for 80 cycles. A melt curve for each qPCR with a single peak at the correct melting temperature was indicative of a reliable and desired PCR product. All the samples and controls were analysed in triplicate, and four calibrator samples were included on each plate to address plate to plate variation. The average Ct values from each triplicate were imported into qBase version 1.2.2 (http:// medgen.ugent.be/qbase/) to calculate the relative gene expression of the genes of interest (TLR1-TLR10) after normalization to the three housekeeping genes, the incorporation of PCR efficiencies, and adjusting for possible plate-to-plate variation using the calibrator samples [14] .
Enzyme-Linked Immunosorbent Assay
Immunoreactive cytokines/chemokines in supernatants from placental explant cultures were measured using commercial ELISA kits according to the manufacturers' instructions: TNFA, IL6, and IL10 (OptEIA; BDBioscien- 
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ces, UK) and IL8 (Pelikine; CLB, The Netherlands). The sensitivity of each of the ELISAs ranged between 1 and 4 pg/ml, and the intra-and interassay coefficients of variation were ,10%.
Statistical Analysis
TLR-mediated cytokine production by nonlabored tissues was evaluated using the two-tailed Student t-test, assuming samples to have unequal variance. Statistical comparison of TLR-mediated cytokine production by labored and nonlabored tissues was made using logarithmically transformed values and the Student t-test for two independent samples. The confidence intervals were calculated for each receptor/agonist in the labored and nonlabored samples by constructing forest plots. Gene expression was compared using the MannWhitney U-test for two independent samples. The differences were considered to be statistically significant when P , 0.05.
RESULTS
Gene Expression
Transcripts for TLR1-TLR10 were expressed in all of the placentae studied (n ¼ 11 ECS and n ¼ 12 NVD). An example for one placenta (ECS) is shown ( Fig. 1) and includes a negative control (water) and a positive control (human spleen).
Response of Term Nonlabored Placental Explants to Various TLR Agonists
Preliminary investigations (n ¼ 9) revealed that CpG oligonucleotide (1 lM) did not induce the production of any   FIG. 2 . Cytokine outputs of term nonlabored placental explants in response to TLR ligands. Placental explant cultures (n values are shown on the x-axes) were prepared as described in the Materials and Methods and stimulated with PGN, I:C, LPS, flagellin, R848, ss Poly, Lox, and CpG oligonucleotide, and the levels of (A) TNFA, (B) IL10, (C) IL6, and (D) IL8 detectable in the culture supernatants after 24 h were determined. Statistically significant differences compared to unstimulated controls are shown: * P , 0.05; ** P , 0.001; *** P , 0.0001; **** P , 0.00001; ***** P , 0.000001; ****** P , 0.0000001. The error bars represent SEM. 
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of the cytokines/chemokines included in this study. Biological activity of the CpG was confirmed by the ability of the same preparation of ligand to induce IFNA production by human peripheral blood mononuclear cells (data not shown). Poly I:C, loxoribine (Lox), and ss Poly did not induce production of TNFA or IL10 but did induce significant increases in IL6 alone, IL8 alone, and both IL6 and IL8, respectively (Fig. 2) . PGN, LPS, flagellin, and R848 all induced statistically significant increases in TNFA, IL6, IL8, and IL10 levels in placental explant cultures (n ¼ 17; Fig. 2) . Notably, IL6 and IL8 were produced constitutively with production further significantly enhanced by the ligands.
Comparison of Activity of TLR1-TLR10 Between Nonlabored and Labored Groups
Preliminary analysis using forest plots for each of the cytokines assayed (Fig. 3, A-D) revealed that the TLR- 246 mediated cytokine outputs that differed significantly consisted of increased TNFA production in the labored group in response to LPS (P ¼ 0.01) and R848 (P ¼ 0.01) (Fig. 4, A and B) .
Comparison of the Expression of mRNA for TLR1-TLR10 Between the Nonlabored and Labored Groups
Generally, the mRNA expression of all the TLR genes was greater in the labored than the nonlabored group. However, a statistically significant difference was found only for TLR2 and TLR5 (Fig. 5, A-J) .
DISCUSSION
This study shows for the first time that the human term placenta can respond to TLR3, TLR5, and TLR7/8 agonists in addition to those for TLR2 and TLR4 as already described [7] . In accordance with published data, transcripts for TLR1-TLR10 were detectable in all nonlabored and labored term human placentas studied [4, 5] . A statistically significant increased production of at least one of the various cytokines studied (TNFA, IL6, IL10, and IL8) was detected for all TLRs studied other than TLR9. TLR2, TLR4, TLR5, and TLR7/8 ligands were able to stimulate production of all four cytokines studied, including significantly increased IL6 and IL8 in comparison to high constitutive levels. Because TLR3 has been demonstrated to be the only TLR that signals via MyD88-independent mechanisms alone [15] , responsiveness by the third trimester placenta and first trimester trophoblast cells to TLR3 ligands [11] indicate that the placenta utilizes both MyD88-dependent and -independent pathways for TLR signaling.
There were statistically significantly increased levels of TNFA in response to a TLR4 agonist (LPS) and a TLR7/8 agonist (R848) in the labored compared to the nonlabored group. This change in activity could not be explained by an increase in the level of transcripts for these two TLRs in the labored placentas. However, significantly increased TLR2 mRNA and TLR5 mRNA were observed in the labored placentas despite no functional differences for these receptors being detected. Amplified cytokine responses in gestational tissues following labor generally relate to the study of the amnion and/or choriodecidua [16] [17] [18] [19] . When the term placenta is studied, the effect of labor on cytokine production is similar to that presented herein. TNFA, as well as IL1A and IL1B, are all significantly up-regulated in response to labor-associated conditions [12] , but the constitutive and/or LPS-stimulated production of IL6, IL8, and IL10 by the placenta does not differ before (ECS) and after (NVD) labor [1, 12, 18, 20] . This observation highlights the need to consider the expression of TLR proteins in the labored versus nonlabored placenta. At the time of undertaking this study, there was a paucity of antibodies suitable for the study of TLRs, other than TLR2 and TLR4, in this way. Moreover, the placenta is an abundant source of suppressor of cytokine signaling 1, with three-fold greater gene expression than the spleen [5] , and this protein has been identified as a negative regulator of TLR signaling [21] . Variation in expression and activity of this and other negative regulators of TLR function are therefore likely to have a role in TLR responsiveness by the placenta.
The uterine cervix undergoes dramatic remodeling during parturition, and a study of the transcriptome of this tissue revealed a significant decrease in gene expression of TLR3 and TLR5 that could be confirmed by conventional quantitative PCR whereas an apparent up-regulation of TLR2 and TLR4 in the microarray study could not be confirmed [22] . Interestingly, TLR3 and TLR5 repeatedly emerge as abundant in tissues related to reproduction (e.g., in ovary and placenta [4, 5] , and in this study) and consideration of endogenous ligands, in addition to host RNA for TLR3 [23] , for both of these receptors within the pregnant and nonpregnant female reproductive tract should be considered.
The inability to detect a response to CpG oligonucleotides, at least for the cytokines we chose to study, prompted consideration of the ability of this ligand to induce other cytokines, namely IFNA and IFNG but these interferons were not detectable from explants left untreated or treated with CpG oligonucleotides or any of the other agonists used in this study. This supports the observation that interferons are generally not detectable in placental tissue throughout much of pregnancy [24] . Expression of intracellular TLR9 and functional responsiveness to TLR9 agonists have been demonstrated in trophoblastic choriocarcinoma cells lines [6] , and investigation of TLR9 protein expression in the placenta and activation of intracellular signaling cascades in response to CpG oligonucleotides would be worthwhile.
In summary, this study clearly demonstrates that the human term placenta expresses functional TLR2-TLR5, and TLR7/8. To date, placental macrophages, infiltrating haematopoietic cells and trophoblast have been identified and/or postulated to be TLR-expressing cells within the placenta. Further work is required to reveal the relative contribution of different cells type to the response to each TLR ligand in the placenta and other gestation-associated tissues. Moreover, there is a need to undertake more detailed functional analysis of each of the TLR-mediated pathways in placental and other extraembryonic tissues given the accumulating evidence of a central role for NF-jB, a key transcription factor in TLR-mediated inflammation, in the physiology and pathophysiology of labor [25] . It might well be possible that in the placenta the ratio of different TLRs active within a cell could modify the response to a given agonist [26] and that manipulation of TLR activity could yield numerous therapeutic benefits.
